WST Operating Income Growth
West Pharmaceutical Services · Operating Income Growth
WST Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported9.84%period ending
WST TTM Operating Income YoY % (4.36% → 9.84%)
Year-over-year change
High-resolution chart · PNG
WST operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 9.84% | |
| 11.3788% | |
| 3.472% | |
| 5.8202% | |
| 0.8878% | |
| -11.5976% | |
| -16.79% | |
| -15.7553% | |
| -12.0278% | |
| -8.7473% | |
| -5.7361% | |
| -9.1761% | |
| -9.1472% | |
| -2.6672% | |
| 0.7289% | |
| 11.954% | |
| 25.1776% | |
| 47.0725% | |
| 78.9424% | |
| 84.2245% | |
| 79.8432% | |
| 64.9665% | |
| 41.8433% | |
| 23.5044% | |
| 20.0488% | |
| 18.9158% | |
| 21.4461% | |
| 40.3855% | |
| 37.2249% | |
| 26.5835% | |
| 10.8194% | |
| 1.4432% | |
| -6.1939% | |
| -9.3913% | |
| 11.3407% | |
| 13.2911% | |
| 67.6448% | |
| 107.5812% | |
| 54.2768% | |
| 48.125% | |
| -24.2735% | |
| -41.8373% | |
| -29.3407% | |
| -26.5634% | |
| 3.2353% | |
| 20.2652% | |
| 12.069% | |
| 11.0191% | |
| 18.3844% | |
| 15.8742% | |
| 20.2073% | |
| 20.2144% | |
| 10.1227% | |
| 11.5008% | |
| 23.1541% | |
| 47.4041% | |
| 48.5194% | |
| 35.4696% | |
| 21.0817% | |
| -16.7293% | |
| -17.9439% | |
| -13.8915% | |
| -6.9815% | |
| 5.0346% | |
| 14.6838% | |
| -2.0503% | |
| -21.5781% | |
| -4.6139% | |
| 14.7594% | |
| 30.7368% | |
| -2.0295% | |
| -16.8149% | |
| -5.9406% | |
| 9.4949% | |
| 24.5405% | |
| 39.9751% | |
| 39.8892% | |
| 36.3636% | |
| 40.5775% | |
| 39.6522% | |
| 49.7925% | |
| 22.8426% | |
| 10.4027% | |
| -2.2109% | |
| -11.5596% | |
| 90.0322% | |
| 177.2093% | |
| 186.8293% | |
| 104.1199% | |
| 2.3026% | |
| -51.1364% | |
| -51.5366% | |
| -34.878% | |
| -15.5556% | |
| 32.5301% | |
| 16.5289% | |
| 14.8459% | |
| -17.9954% | |
| -34.7741% | |
| -39.2977% |